Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,081.00 +17.44 (+1.64%)

Official Closing Price Updated: 7:00 PM EST, Jan 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Why Tempus AI Stock Rose Today ↗

January 12, 2026

The data provider's artificial intelligence-driven solutions are accelerating drug discovery.

Via The Motley Fool

Topics Artificial Intelligence

Beyond the Protein: How AlphaFold 3 Redefined the Blueprint of Life and Accelerated the Drug Discovery Revolution

January 12, 2026

In the two years since its unveiling, AlphaFold 3 (AF3) has fundamentally transformed the landscape of biological research, moving the industry from simple protein folding to a comprehensive "all-atom"...

Via TokenRing AI

Topics Artificial Intelligence

Anthropic Launches “Claude for Healthcare”: A Paradigm Shift in Medical AI Integration and HIPAA Security

January 12, 2026

On January 11, 2026, Anthropic officially unveiled Claude for Healthcare, a specialized suite of artificial intelligence tools designed to bridge the gap between frontier large language models and the...

Via TokenRing AI

Topics Artificial Intelligence

Nvidia, Lilly Team Up For $1B Drug AI Lab ↗

January 12, 2026

Via Stocktwits

Topics Artificial Intelligence

This NVIDIA Partnership Shows How Big AI Can Really Get ↗

January 12, 2026

Via MarketBeat

Topics Artificial Intelligence

Nvidia Stock Continues To Crawl But Analysts See Strong Upside Ahead ↗

January 12, 2026

Nvidia said on Monday that it will partner with Eli Lilly to fund a new artificial intelligence research lab, committing up to $1 billion over five years.

Via Talk Markets

Topics Artificial Intelligence

Nvidia Partners With Biotech Firms On AI Drug Discovery ↗

January 12, 2026

Nvidia announced AI partnerships with biotech firms to transform the way lifesaving drugs are discovered and manufactured. Nvidia stock rose.

Via Investor's Business Daily

Topics Artificial Intelligence

BioAge Rockets As It Takes On Eli Lilly's Takeover Play, Ventyx Bio ↗

January 12, 2026

BioAge shares catapulted Monday on promising results for the company's cardiovascular diseases treatment.

Via Investor's Business Daily

From Silicon to Syringes: Nvidia’s AI Dominance Solidified Through Landmark Eli Lilly Alliance

January 12, 2026

In a move that signals the definitive convergence of high-performance computing and biotechnology, NVIDIA Corporation (NASDAQ: NVDA) and Eli Lilly and Company (NYSE: LLY) announced a massive $1 billion...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

ABVX Soars Pre-Market On Reports Of $17.5 Billion Eli Lilly Takeover Interest ↗

January 12, 2026

Via Stocktwits

The "Low-Hire, Low-Fire" Safety Net: Labor Resilience Provides Bullish Floor for Wall Street in 2026

January 12, 2026

As the dust settles on the first trading weeks of 2026, the U.S. economy finds itself in a precarious yet surprisingly durable equilibrium. Despite a political landscape fraught with the friction of an...

Via MarketMinute

Topics Artificial Intelligence Economy Initial Public Offering

The AI-Bio Convergence: Lilly and Nvidia Kick Off JPM26 with Landmark $1 Billion Alliance

January 12, 2026

The 44th Annual J.P. Morgan Healthcare Conference opened today in San Francisco with an intensity not seen in years, as the healthcare and technology sectors officially merged their futures. The...

Via MarketMinute

Topics Artificial Intelligence Intellectual Property

The Convergence of Silicon and Science: Eli Lilly and Nvidia Unveil $1 Billion AI Co-Innovation Lab at JPM26

January 12, 2026

In a move that signals the definitive arrival of the "AI-first" era for the pharmaceutical industry, Eli Lilly and Company (NYSE:LLY) and NVIDIA Corporation (NASDAQ:NVDA) announced a massive expansion...

Via MarketMinute

Topics Artificial Intelligence

OCGN Stock Rises Pre-Market After Gene Therapy Data Shows Promise In Rare Eye Disorder ↗

January 12, 2026

Stargardt disease is a form of inherited macular degeneration, affecting more than 100,000 people in the U.S. and Europe combined.

Via Stocktwits

An Investor's Guide to 2026 ↗

January 12, 2026

What does the new year bring to investors?

Via The Motley Fool

Topics Artificial Intelligence Economy

Stocks to Love in 2026 ↗

January 11, 2026

Are you looking for investment opportunities in 2026?

Via The Motley Fool

Topics ETFs Initial Public Offering

Can This Stock Double Again in 2026? ↗

January 11, 2026

It's a tough act to follow.

Via The Motley Fool

Is the Schwab U.S. Dividend Equity ETF a Buy Now? ↗

January 11, 2026

It's time to start thinking strategically -- and even philosophically -- about how seemingly similar funds are actually quite different.

Via The Motley Fool

Topics ETFs Stocks

This ETF Is Proof That the Healthcare Rebound Is Real ↗

January 11, 2026

Via MarketBeat

Topics ETFs

This Healthcare Stock Could Be One of the Best Companies to Own in 2026 ↗

January 11, 2026

It has strong momentum thanks to its current portfolio and several catalysts on the horizon.

Via The Motley Fool

Novo Nordisk Is Getting a Major Boost from Amazon for Its New Wegovy Pill. Does That Make NVO Stock a Buy Here?

January 09, 2026

Novo Nordisk shares inch higher as the pharma giant announces an oral Wegovy partnership with Amazon Pharmacy. Here’s why NVO stock is worth owning at current levels.

Via Barchart.com

Eli Lilly Solidifies Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences

January 09, 2026

In a move that underscores the tightening intersection between metabolic health and systemic inflammation, Eli Lilly and Company (NYSE: LLY) officially announced on January 7, 2026, its definitive...

Via MarketMinute

Cashing In at the Peak: Olema Pharmaceuticals Insiders Sell $8 Million in Stock After 300% Surge

January 09, 2026

Olema Pharmaceuticals (NASDAQ:OLMA) has become the latest focal point of biotech volatility and executive opportunism. Following a staggering 300% surge in its share price over the past year—fueled by...

Via MarketMinute

The Great Pricing Pivot: Novo Nordisk Launches Wegovy Pill in Bid to Reclaim US Market Dominance

January 09, 2026

As the first full week of 2026 unfolds, the pharmaceutical landscape is witnessing a seismic shift led by the Danish healthcare giant Novo Nordisk (NYSE: NVO). On January 5, 2026, the company...

Via MarketMinute

Topics Economy

The Trillion-Dollar Pharmacist: A 2026 Deep Dive into Eli Lilly (LLY)

January 09, 2026

As of January 9, 2026, Eli Lilly and Company (NYSE:LLY) has transitioned from a stalwart of the American pharmaceutical industry to a global financial phenomenon. Having recently crossed the historic...

Via PredictStreet

Topics Earnings Economy Intellectual Property

MoonLake Immunotherapeutics Surges as FDA "De-Risks" Sonelokimab, Reigniting Multi-Billion Dollar Takeover Speculation

January 09, 2026

MoonLake Immunotherapeutics (NASDAQ: MLTX) shares have experienced a dramatic resurgence this week, climbing over 40% following a pivotal regulatory update that has effectively cleared the path for its...

Via MarketMinute

Topics Intellectual Property

The WeightWatchers Rebirth: A Clinical Transformation and the GLP-1 Era

January 09, 2026

As of January 9, 2026, WW International, Inc. (NASDAQ: WW), better known as WeightWatchers, stands at the most pivotal juncture in its 63-year history. After a tumultuous 2024 and 2025 that saw the...

Via PredictStreet

Topics Artificial Intelligence Bankruptcy

Eli Lilly Study Finds Zepbound Dual Treatment Improves Arthritis, Helps Patients Lose Weight ↗

January 09, 2026

Eli Lilly said combining Taltz and Zepbound improved arthritis symptoms and drove meaningful weight loss, outperforming Taltz alone in a late-stage trial.

Via Benzinga

The Great Rotation: Investors Pivot to Defensive Moats as Tech Giants Face 'AI ROI' Audit

January 08, 2026

As the first full trading week of 2026 comes to a close, a seismic shift is rattling Wall Street. The high-flying technology sector, which dominated the market narrative throughout 2024 and 2025, is...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Nvidia’s $5 Trillion Peak Sparks Massive Nasdaq Retreat as Investors Pivot to Value

January 08, 2026

The tech-heavy Nasdaq Composite faced a stark reversal on January 8, 2026, as a wave of profit-taking in high-flying artificial intelligence stocks, led by Nvidia (NASDAQ: NVDA), dragged the index...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.